Melvin Chua/X
Jun 15, 2025, 20:42
Melvin L.K. Chua: Discussing Nasopharyngeal Carcinoma Advances in Guangzhou
Melvin L.K. Chua, Head of Department of Head Neck and Thoracic Cancers at National Cancer Centre Singapore, shared a post on LinkedIn:
“Always nice to visit Guangzhou 🇨🇳for another Nasopharyngeal Carcinoma, Proton Therapy meeting to discuss practice in the real world.
OS rates may be improving >70%, BUT still lots of patients with bad disease and early relapse so lots more to do! Thanks to Prof Mai for the invitation! Great learning from all the Chinese experts in China on the next frontiers of clinicaltrials in this disease. “
More posts featuring Melvin L.K. Chua.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 15, 2025, 20:42
Jun 15, 2025, 16:56
Jun 15, 2025, 16:47
Jun 15, 2025, 16:38